MOPH

TAXOTERE - 20mg/ml - 1 x 0.5ml + 1.5ml

ATC	B/G	Ingredients	code	Registration Nb	brand_name	Dosage	Presentation	Form	Route	Agent	Laboratory	man_country	Price	Pharmacist Margin	Startum	Responsible Party Name	Responsible Party Country	Exch_date	%SUBSIDY
L01CD02	B	Docetaxel (trihydrated) - 20mg/ml	1780	208396/97	TAXOTERE	20mg/ml	1 x 0.5ml + 1.5ml	Injectable concentrated solution+diluent	Infusion	Mersaco	Sanofi Aventis Deutschland GmbH	Germany	6,574,078 L.L	23.08	B	Aventis Pharma SA	France	2/5/2024	0

ATC	B/G	Ingredients	code	Registration Nb	brand_name	Dosage	Presentation	Form	Route	Agent	Laboratory	man_country	Price	Pharmacist Margin	Startum	Responsible Party Name	Responsible Party Country	Exch_date
L01CD02	B	Docetaxel (trihydrated) - 20mg/ml	11068	81822/1	TAXOTERE	20mg/ml	1 x 0.5ml + 1.5ml	Injectable concentrated solution+diluent	Infusion	Mersaco	Sanofi Aventis Deutschland GmbH	Germany	6,574,078 L.L	23.08	B	Sanofi Mature IP	France	2/5/2024
L01CD02	G	Docetaxel - 20mg/ml	8734	56816/1	DOCETAXEL ACCORD	20mg/1ml	1	Injectable concentrate for solution	Infusion	Mediterranean Pharmaceutical Company	Accord Healthcare Limited	UK	4,110,814 L.L	23.08	B	Accord Healthcare Limited	UK	2/5/2024
L01CD02	G	Docetaxel - 20mg/2ml	5867	218936/10	DOCETAXEL EBEWE	20mg/2ml	1	Injectable solution	Infusion	Khalil Fattal & Fils S.A.L.	Fareva Unterach GmbH	Austria	5,313,553 L.L	23.08	B	Ebewe Pharma GesmbH.NFG.KG	Austria	2/5/2024
L01CD02	G	Docetaxel - 40mg/ml	3576	194595/04	DOCETAXEL GP PHARM	20mg/0.5ml	1 x 0.5ml + 1.5ml	Injectable concentrated solution+diluent	Infusion	Mediterranean Pharmaceutical Company	GP-Pharm, SA	Argentine	4,567,721 L.L	23.08	B			2/5/2024